Videoconference Brief Cognitive Behavioral Therapy for mood disorders at high suicide risk
Official title: Efficacy of Videoconference-Based Brief Cognitive-Behavioral Therapy (V-BCBT) for Patients With Mood Disorders at High Risk for Suicide: Identifying Inflammatory Biomarkers of Suicide Risk and Examining Their Mediating Role in Treatment Effects
Run by Asan Medical Center · NCT07857291 · Data updated 2026-11-12
This study tests a short online CBT program to help people with mood disorders who are at high risk of suicide, and compares inflammatory biomarkers between groups.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | All |
| Enrollment | 320 (estimated) |
| Sponsor | Asan Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | November 4, 2026 |
| Main results expected | August 2031 |
| Study ends | August 2031 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT07857291 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18-64 with a depressive or bipolar disorder in a current major depressive episode, including those at high suicide risk or low risk, and healthy controls without DSM-5 psychiatric history.
✕Probably not a fit
Patients with active psychosis, current substance use disorder, significant inflammatory/immune disorders, recent pregnancy, cancer, or recent psychotherapy may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study has a cross-sectional baseline comparison followed by a randomized controlled trial to examine inflammatory biomarkers related to suicide risk and to test the effectiveness of videoconference-based brief cognitive-behavioral therapy (V-BCBT) in mood disorder patients. Participants include adults with depressive disorders or bipolar and related disorders, some at high suicide risk and others at low risk, plus healthy controls. All participants will undergo clinical interviews, self-report questionnaires, a Death Implicit Association Test, and blood sampling to profile inflammatory markers. The intervention arm receives V-BCBT, while the control arm receives treatment as usual, with outcomes including mood symptoms and suicidality, as well as biomarker correlations. The study aims to identify biomarkers linked to suicide risk and to assess whether V-BCBT can reduce risk indicators and improve clinical outcomes.
Why it matters
Potential benefit: If successful, participants at high suicide risk may experience reductions in suicidal thoughts and mood symptoms, along with possible biomarker changes linked to lower risk.
How similar studies have gone: Prior work in online CBT has shown benefits for mood symptoms; this study adds biomarker assessment and a suicide-risk focus, representing a somewhat novel combination.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 to 64 years. * For patient groups: diagnosis of a depressive disorder or bipolar and related disorder with a current major depressive episode according to DSM-5 criteria, as assessed using the Mini International Neuropsychiatric Interview (MINI). * For the high-suicide-risk group: either a suicide attempt within the past month or a Beck Scale for Suicide Ideation (SSI) score of ≥15. * For healthy controls: no lifetime history of any DSM-5 psychiatric disorder, as assessed using the MINI. Exclusion Criteria: * Presence of psychotic symptoms or a current substance use disorder. * Diagnosis of an inflammatory or autoimmune disease. * Use of corticosteroids or immunosuppressive medications within the past month. * Current pregnancy or breastfeeding. * Diagnosis of cancer within the past 5 years. * Physical injury or infectious illness within the past month. * Night-shift work within the past 2 months. * Receipt of psychotherapy or psychological treatment within the past 3 months. * Use of anti-inflammatory medications within the past 2 weeks.
Where it's running
-
Asan Medical Center
Seoul, South Korea Recruiting
Study contacts
- Study coordinator: Christopher Hyung Keun Park, M.D., Ph.D.
- Email: hkpark@gmail.com
- Phone: +82-2-3010-1657
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New Generation Therapies for Suicide: Refining Brief Cognitive Behavioral Therapy
This study tests different sequences and doses of Brief Cognitive Behavioral Therapy to see if it better reduces suicide risk in adults with recent suicidal thoughts or behavior.
-
Digital Mental Health support for Asian Americans
We’re testing online digital tools to help Asian American adults cope with sociocultural stressors, by training clinicians and seeing if outcomes improve for clients.
-
Brief Cognitive Behaviour Therapy to Prevent Suicide Reattempts in Swedish Psychiatric Inpatient Care
This study tests whether four brief CBT sessions can be delivered during a psychiatric hospital stay to help adults who recently attempted suicide or are at high risk see if the treatment works and is easy to use in routine care.
-
Youth-Nominated Support Team for Probation to prevent suicide in teens
This pilot tests a program that trains nominated adults to support 12–17-year-olds on probation who are having suicidal thoughts or behaviors, helping them get mental health care and reduce suicide risk.
-
Suicide risk and learned suicide ability in people with mood disorders
This project will try to identify which biological, psychological, social, and clinical factors relate to suicide risk and the learned ability for suicide in people aged 16–60 with mood disorders by collecting blood, urine, and questionnaire data.
-
Safety Planning Intervention rollout in Swedish psychiatric services to prevent suicide
This project will try a single-session Safety Planning Intervention with adults who present to psychiatric emergency or inpatient units with suicidal thoughts or attempts to see if it reduces suicide-related emergency visits and hospitalizations.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.